NCT02275351View on ClinicalTrials.gov

A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)

PHASE2CompletedINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Androgenetic Alopecia
Interventions
DRUG

SM04554

Topical solution, applied once a day

DRUG

Vehicle

Topical solution, applied once a day

Trial Locations (24)

11790

Stony Brook

23507

Norfolk

24501

Lynchburg

27104

Winston-Salem

33143

Miami

33401

West Palm Beach

44195

Cleveland

48038

Clinton Township

48202

Detroit

55432

Fridley

67207

Wichita

75246

Dallas

77845

College Station

78759

Austin

84117

Salt Lake City

87106

Albuquerque

92024

Encinitas

92123

San Diego

97210

Portland

97223

Portland

06511

New Haven

Unknown

Plainfield

New York

Houston

Sponsors
All Listed Sponsors
lead

Biosplice Therapeutics, Inc.

INDUSTRY